Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2001
11/20/2001US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
11/20/2001US6319900 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
11/20/2001US6319897 Peptides which inhibit complement activation
11/20/2001CA2025599C Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
11/19/2001CA2308994A1 Neuroprotective compounds
11/15/2001WO2001085986A2 Phosphatidyl inositol 3-kinase delta binding partner
11/15/2001WO2001085959A2 Regulation of human lysostaphin-like protease
11/15/2001WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001WO2001085726A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001WO2001085721A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23
11/15/2001WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001WO2001085715A2 Aza- and polyazanthranyl amides and their use as medicaments
11/15/2001WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001WO2001085257A2 Opioid antagonist compositions and dosage forms
11/15/2001WO2001085256A2 Critical illness neuropathy
11/15/2001WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001WO2001085191A1 Hyaluronidase activity and allergenic cell activity inhibitor
11/15/2001WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001WO2001085150A2 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
11/15/2001WO2001085143A2 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
11/15/2001WO2001085096A2 Mast cell regulation
11/15/2001WO2001041733A3 Compressed tablet composition comprising a nsaid
11/15/2001WO2001036001A3 Interferon gamma conjugates
11/15/2001WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001WO2000063379A3 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
11/15/2001WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001WO2000045834A9 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
11/15/2001US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001US20010041711 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (ORL1) receptor
11/15/2001US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001US20010041676 Systemic, transdermal, intranasal or inhalation administration of a glucocorticosteroid in the form of glucosides or orthoester glucoside to treat adrenal insufficiency, inflammatory or immune system diseases
11/15/2001US20010041671 Ophthalmic formulations
11/15/2001US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
11/15/2001US20010041177 Biomarker molecule CD163, antibody complex
11/15/2001DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001CA2408665A1 Novel regulator of g protein signalling
11/15/2001CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001CA2408448A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001CA2408293A1 Novel vitronectin receptor antagonists
11/15/2001CA2408106A1 Opioid antagonist compositions and dosage forms
11/15/2001CA2408098A1 Opioid antagonist containing composition for enhancing the potency or reducing adverse side effects of opioid agonists
11/15/2001CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001CA2407850A1 Cytoskeleton-associated proteins
11/15/2001CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/14/2001EP1153610A1 Matrix protein compositions for inflammatory and infectious conditions
11/14/2001EP1153302A1 Diagnostics and therapeutics for macular degeneration
11/14/2001EP1153301A1 Diagnostics and therapeutics for arterial wall disruptive disorders
11/14/2001EP1153125A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/14/2001EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001EP1153022A1 Prothease inhibitors
11/14/2001EP1153017A1 Bicyclic compounds and their use as integrin receptor ligands
11/14/2001EP1153015A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
11/14/2001EP1153014A2 Beta-alanine derivatives
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001EP1152761A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
11/14/2001EP1152760A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
11/14/2001EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001EP1152753A1 Combinations of formoterol and fluticasone propionate for asthma
11/14/2001EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001EP0894002A4 Novel peptides which inhibit complement activation
11/14/2001EP0815087B1 Trisubstituted phenyl derivatives
11/14/2001EP0777482B1 Combined preparation for the therapy of immune diseases
11/14/2001EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001EP0722322B1 Compounds, compositions and treatment of allergies and inflammation therewith
11/14/2001EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001CN1322246A Restin and methods of use thereof
11/14/2001CN1322244A Tumor necrosis factor-gamma
11/14/2001CN1322213A Treatment of inflammatory disease
11/14/2001CN1322212A Neuropeptide Y agaonists
11/14/2001CN1322202A Quinazoline derivatives
11/14/2001CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001CN1322133A Vitronectin receptor antagonists
11/14/2001CN1322131A Nimesulide containing topical pharmaceutical compositions
11/14/2001CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001CN1321507A Chinese medicine for curing rheumatoid disease and preparing method thereof
1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 1272